article · BMJ Open

Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort

Lorraine Boois
Hilya Ekandjo
Desiree C. Petersen
Helen McIlleron
C. OELOFSE
Marie Wijk
Olga Shavuka
Tracy Kellermann
Emmanuel Nepolo
P. Denti
Caitlin Uren
Möller Marlo
Carene Anne Ndong Sima
Eric Decloedt
Mareli Misha Claassens

2026Open accessStellenbosch University

Abstract

Ethics approval was obtained from the University of Namibia Human Research Ethics Committee for Health (Ref. SOM18/2024), the Ministry of Health and Social Services (Ref. 22/4/2/3), the SU Health Research Ethics Committee (Ref. N21/11/136) and the University of Cape Town Human Research Ethics Committee (Ref. 500/2022).

Research topics

Tuberculosis Research and Epidemiology
Pharmacogenetics and Drug Metabolism
Pharmaceutical Quality and Counterfeiting

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1136/bmjopen-2025-109764

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.